Private Equity Firms Zurich: Top Firms in 2026

Key Facts

• The Canton of Zurich and its neighboring cantons host 168 private equity and venture capital firms, with 106 concentrated in Canton of Zurich alone, per a February 2025 economic affairs report.
• Partners Group, headquartered in Baar (Zug), has invested USD 244 billion across private markets since 1996 and ranks 28th globally by five-year fundraising totals at USD 27.3 billion.
• Zurich, Geneva, and Baar/Zug form the three dominant clusters of Swiss PE activity, supported by favorable tax regimes and FINMA regulatory oversight.
• DACH mid-market buyout is the leading direct investment strategy, with Capvis targeting companies at enterprise values between €30 million and €300 million.
• Secondary PE transactions are a growing specialty: Multiplicity Partners has completed 500-plus transactions and closed its LTO Fund IV at a USD 160 million hard cap in early 2025.
• A February 2025 Canton of Zurich report identifies a structural gap in growth-stage funding and recommends larger vehicles suited to pension fund capital.
• Swiss family offices in the Zurich region manage approximately CHF 600 billion, forming a substantial limited partner base for local fund managers.

Zurich and Switzerland as a Private Equity Hub

The Canton of Zurich concentrates 63 percent of the 168 PE/VC firms counted in the broader Zurich region as of early 2025. Zug, 25 kilometers south, adds marquee names including Partners Group and Capvis. Corporate tax rates there rank among the lowest in Europe. Geneva anchors the western cluster, home to Unigestion, Stoneweg, and Edmond de Rothschild Asset Management.

Switzerland's appeal to PE general partners extends well beyond tax efficiency. FINMA regulation provides institutional credibility, and political stability reduces structural risk for long-duration fund vehicles. The Zurich region hosts roughly 250 to 300 single-family offices managing approximately CHF 600 billion. Combined with pension funds and endowments, they provide a consistent LP capital base.

The Canton of Zurich's February 2025 economic report signals a strategic inflection point. It identifies a fundamental gap in growth-stage investment. The report recommends promoting larger vehicles structured for pension fund participation, a shift that could redirect significant institutional capital into earlier-stage Swiss companies over the coming decade.

Zurich Private Equity Firms: Firm Comparison

The firms below represent the primary independent PE managers and specialist platforms based in the Swiss financial center. Bank-affiliated wealth management arms managing broad multi-asset strategies are excluded to focus on dedicated private markets operators.

The two firms with the broadest mandates are Partners Group and Unigestion, both offering multi-strategy private markets access at institutional scale. The secondaries niche is unusually well-developed for a market of this size, with Montana Capital Partners, Multiplicity Partners, and Blue Earth Capital all active in LP stakes, GP-led continuation vehicles, or complex secondary transactions.

Top Picks by Investment Strategy

Largest Private Markets Platform: Partners Group ranks 28th globally by five-year fundraising at USD 27.3 billion. Since its founding, the firm has deployed USD 244 billion across PE, infrastructure, real estate, and private credit.

DACH Mid-Market Buyout Leader: Capvis targets majority control transactions in companies with enterprise values between €30 million and €300 million, focusing on industrial technology, software, and healthcare across German-speaking Europe.

Healthcare PE Specialist: ArchiMed invests exclusively in biopharma, medtech, diagnostics, and healthcare IT, with a value creation track record exceeding €10 billion and deal sizes ranging from €10 million to €1 billion.

Most Active Secondaries Manager: Multiplicity Partners has completed 500-plus transactions in illiquid and tail-end secondary assets, closing LTO Fund IV at its USD 160 million hard cap in February 2025.

Strongest Impact Track Record: Blue Earth Capital has committed USD 355 million to environmental strategies and USD 588 million to social impact investments, with portfolio companies including Sunfire (green hydrogen) and Tyme Group (digital banking).

Growth Equity and Fund-of-Funds: Unigestion, managing CHF 22.7 billion from Geneva, combines private equity fund-of-funds with growth equity strategies for institutional investors seeking diversified private markets exposure.

Mid-Market Secondaries Liquidity Specialist: Montana Capital Partners, FINMA-regulated since its 2011 founding, focuses on €40 million to €80 million secondary transactions covering LP stake purchases and GP-led continuation vehicles across Europe and North America.

Top Private Equity Firms in Zurich and Switzerland in Detail

Partners Group

Partners Group is the anchor of the Swiss private equity ecosystem, having raised USD 27.3 billion over the past five years and secured rank 28 in global PE fundraising. No other Switzerland-based manager approaches this scale. Its investment thesis spans private equity, infrastructure, real estate, private credit, and royalties. This gives limited partners a single-manager entry point to the full private markets spectrum through a Zug-domiciled general partner. Recent portfolio activity includes the Esentia Energy Development IPO, the acquisition of the Hoxton Hotel in Barcelona, and the exit of an Australian wind farm stake. Partners Group also incubated Blue Earth Capital, now operating as an independent impact firm, making it a net creator of institutional capacity within the wider Swiss ecosystem.

Capvis

The defining mid-market buyout franchise in DACH, Capvis has spent more than three decades building regional niche champions across industrial technology, advanced services, software, healthcare, and manufacturing. Its majority control model targets enterprise values of €30 million to €300 million, mapping directly to the ownership profile of family-held and corporate spin-out businesses across Germany, Austria, and Switzerland. Several billion euros deployed across dozens of transactions produce a track record spanning full economic cycles. Newer DACH-focused competitors cannot yet match this vintage depth. For succession-driven businesses in German-speaking markets, Capvis remains the benchmark majority-control buyer.

Montana Capital Partners

Montana Capital Partners specializes in the mid-market segment of European PE secondaries, a structuring-intensive niche that generalist firms rarely develop the expertise to execute consistently. Since its 2011 founding, the FINMA-regulated firm has closed multiple funds at hard caps and completed over 100 secondary transactions, building relationships with hundreds of GPs across Europe and North America. Its target deal size of €40 million to €80 million sits below the radar of mega-fund secondary platforms. This positioning allows more favorable pricing dynamics and reduced sourcing competition. Institutional sellers of LP stakes or fund managers exploring GP-led continuation vehicles in the mid-market will find Montana Capital Partners among the most experienced Swiss-regulated counterparties available.

Multiplicity Partners

With 500-plus completed transactions across illiquid funds and complex assets, Multiplicity Partners has built one of the deepest proprietary databases of tail-end and special situations secondaries in Europe. The Zurich-based firm obtained its FINMA license in 2024. It then closed LTO Fund IV at its USD 160 million hard cap in February 2025, supported by demonstrated fund-level returns from the LTO series since 2016. Its focus on assets other secondary buyers actively avoid (expired fund vehicles, concentrated positions, and complex illiquid structures) produces a differentiated return profile relative to mainstream secondary platforms. LPs holding positions in older or structurally complex fund vehicles represent the primary audience for Multiplicity Partners' liquidity solutions.

Blue Earth Capital

Blue Earth Capital's ownership structure is its most distinctive competitive feature: the firm is owned by a foundation, and its performance fee flows to the Blue Earth Foundation rather than to individual partners. This eliminates the incentive misalignment that critics identify in conventional PE structures, supporting a credible dual-mandate model for investors with environmental or social return requirements. Its USD 0.9 billion in committed capital spans private equity, credit, funds, co-investments, and secondaries across both environmental and social themes. Portfolio companies include Sunfire, a green hydrogen electrolyzer manufacturer, and Tyme Group, a digital bank serving lower-income consumers in South Africa and the Philippines. Quadria Capital, a healthcare-focused growth equity manager in South Asia, rounds out the portfolio thesis. Incubated by Partners Group, Blue Earth Capital combines institutional-grade processes with genuinely differentiated impact governance.

ArchiMed

ArchiMed invests exclusively in healthcare and life sciences, covering biopharma, medtech, diagnostics, healthcare IT, and consumer health across Europe, North America, and Asia. Its funds have achieved top-decile performance against comparable vintage years, with an aggregate value creation track record exceeding €10 billion. The investment range from €10 million to €1 billion gives ArchiMed the flexibility to lead early growth rounds as well as significant buyout transactions. Few sector-specialist firms operate across this breadth of deal size. Healthcare founders and management teams seeking a partner with deep regulatory knowledge across multiple geographies have no stronger dedicated option within the Swiss-connected PE ecosystem.

Unigestion

Managing CHF 22.7 billion from Geneva, Unigestion combines private equity fund-of-funds with multi-asset and liquid alternatives, serving institutional investors who value systematic risk management alongside private markets access. Operating since 1971, the firm carries one of the longest independent track records among Swiss asset managers, with a vintage history spanning multiple credit and equity cycles. Its approach to private equity emphasizes consistent, risk-adjusted returns over peak-vintage concentration. This suits pension funds and foundations seeking stable long-term performance rather than high-variance upside in any single fund year.

Amundi Alpha Associates

The integration of Zurich-based Alpha Associates into Amundi's platform created one of the largest private markets multi-manager operations with Swiss institutional roots. Operating under Swiss financial regulatory authorization, Amundi Alpha Associates constructs diversified private markets allocations through fund-of-funds and bespoke managed accounts covering private equity, private debt, and infrastructure. Institutional investors who want customized access to private markets without the complexity of managing direct GP relationships represent its core client base. Amundi's broader global platform adds GP access and scale that the standalone Alpha Associates operation could not have matched independently.

Stoneweg

Trans-European real estate is Stoneweg's sole focus, and 700-plus property acquisitions since its 2015 Geneva founding demonstrate a high-velocity execution model rarely seen among boutique real estate PE managers. The firm operates across Switzerland, Spain, Italy, Ireland, Andorra, and the United States, combining residential and commercial strategies within a single investment platform. Real estate investors seeking pan-European property exposure through a single manager with proven acquisition pace will find Stoneweg the most operationally active real estate PE operator based in the Swiss financial center.

Investment Trends Shaping Swiss Private Equity

Secondary Market Expansion

Switzerland has emerged as a specialist hub for PE secondary transactions. Montana Capital Partners, Multiplicity Partners, and Blue Earth Capital all execute LP stake purchases, GP-led continuation vehicles, and complex secondaries. A global alternatives manager opened a Zurich office in 2025 with PE secondaries as a core strategy, reinforcing the city's position as a secondary deal center for European managers. FINMA regulation, proximity to European GP networks, and access to Swiss institutional LP capital give Zurich-based secondary managers structural sourcing advantages over competitors in less regulated or capital-sparse markets.

Healthcare and Life Sciences Consolidation

ArchiMed's €10 billion-plus value creation track record reflects broader capital concentration in European healthcare PE, driven by aging demographics, regulatory complexity favoring larger operators, and cross-border M&A in biopharma and medtech. Blue Earth Capital's investment in Quadria Capital extends this healthcare exposure into high-growth South Asian markets. Swiss PE managers are increasingly positioned as capital allocators between European healthcare assets and global institutional investors.

Growth-Stage Funding Gap

The Canton of Zurich's February 2025 report identifies a structural gap in growth-stage investment. Existing fund structures are poorly suited to pension fund participation at scale. The 2024 tax policy change enabling Canton of Zurich foundations to invest in startups removes one regulatory obstacle. Pension funds and large family offices are the most likely sources of capital to fill this gap, creating an opening for new vehicles positioned between venture capital and traditional mid-market buyout.

ESG and Impact Investing Mainstreaming

Blue Earth Capital and AlphaMundi represent the dedicated impact end of the Swiss PE spectrum, while Edmond de Rothschild Asset Management and EFG integrate ESG frameworks across conventional strategies. Several Swiss PE managers are partnering with sustainability bodies such as the Center for Sustainable Finance and Private Wealth, reflecting an industry-wide shift toward measurable ESG integration rather than voluntary disclosure. LP pressure to quantify impact alongside financial returns is intensifying, reinforced by FINMA's evolving sustainable finance regulatory guidance.

DACH Mid-Market Succession Wave

A generational ownership transition is creating deal flow in German-speaking Europe's Mittelstand. Founders who built industrial and services businesses in the 1980s and 1990s are now seeking succession exits. Capvis explicitly includes succession and spin-out transactions within its majority control mandate, giving it a structural claim on this deal flow. The typical enterprise value range of €30 million to €300 million aligns precisely with the size distribution of privately held DACH companies approaching ownership transition.

How to Evaluate Swiss PE Managers

Start with FINMA authorization. Swiss-domiciled PE fund managers require a FINMA license or registration under FinIA/FinSA. Any manager without confirmed regulatory status represents an immediate due diligence concern. Montana Capital Partners and Multiplicity Partners both hold FINMA licenses; other managers operate under FinIA and FinSA registration. Verifying status takes minutes and eliminates unregulated operators from the shortlist.

Sector specialization depth matters more than breadth for mid-market transactions. ArchiMed's healthcare-only mandate produces a GP team with medical sector knowledge that generalist firms cannot replicate. This translates to better deal sourcing, faster due diligence, and stronger portfolio company support. Whether a firm's investment thesis matches your sector is more predictive of fit than assets under management alone.

Fund size alignment with deal size is the practical filter most founders and LPs overlook. A firm managing USD 5 billion cannot write €15 million checks without misallocating capital. A USD 160 million fund, equally, cannot participate in €500 million transactions. Matching fund size to expected transaction size is a necessary first screen before pursuing conversations.

For LPs assessing internal rate of return benchmarks, fund vintage data from PE industry databases allows direct comparison of a Swiss manager's performance against global quartile benchmarks. Top-decile claims, such as ArchiMed's, should be verified against vintage comparables rather than accepted from self-reported materials in isolation. Request audited performance data and assess management team tenure as a leading indicator of future execution quality.

Which Firm Fits Your Needs?

Founders and management teams in industrial technology, healthcare, or advanced services with enterprise values between €30 million and €300 million should engage Capvis first. Its DACH-market focus, majority control model, and succession transaction expertise match the profile of family-owned or corporate spin-out businesses in German-speaking Europe. These businesses typically need a structured exit with ongoing operational support, and Capvis provides both.

LPs building diversified private markets allocations can access Swiss-managed platforms through Unigestion's fund-of-funds strategies or Amundi Alpha Associates' bespoke managed accounts. Both aggregate GP relationships that most institutional investors could not replicate through direct commitments. Pension funds with ESG mandates have a clear path through Blue Earth Capital, whose foundation ownership model and audited impact metrics satisfy dual-mandate requirements that conventional PE managers cannot credibly meet. For LPs holding positions in older or structurally complex fund vehicles and seeking early liquidity, Multiplicity Partners and Montana Capital Partners are the two most active mid-market secondary buyers with Swiss regulatory standing.

Healthcare investors with a global mandate should evaluate ArchiMed's vintage track record directly. Its combination of European, North American, and Asian deal flow alongside top-decile performance data makes it the strongest purely healthcare PE option accessible through a Swiss-connected platform.

Methodology

This guide to private equity firms in Zurich covers firms identified through the Canton of Zurich's February 2025 PE/VC ecosystem report, individual firm disclosures, global PE fundraising ranking data, and publicly available fund closing announcements. Firm profiles reflect data available as of early 2026. AUM figures are sourced from firm disclosures or industry fundraising databases and represent invested capital or assets under management as stated by each firm. Where no figure was publicly available, no number is stated. Firms were selected based on Swiss headquarters or significant Swiss operating presence, independent PE or specialist investment mandates, and verifiable fund or transaction data. The article focuses on independent PE and alternative investment managers with dedicated private markets mandates rather than bank-affiliated wealth management arms managing broad multi-asset strategies.